Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma

被引:50
作者
Li, W [1 ]
Xu, RJ
Jiang, LH
Shi, JF
Long, X
Fan, B
机构
[1] First Peoples Hosp Hangzhou, Dept Gynecol & Obstet, Hangzhou 310006, Zhejiang, Peoples R China
[2] First Peoples Hosp Hangzhou, Dept Pathol, Hangzhou 310006, Zhejiang, Peoples R China
关键词
cyclooxygenase; inducible nitric oxide synthase; endometrial carcinoma; tumor angiogenesis; immunohistochemistry;
D O I
10.1385/MO:22:1:063
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The present study evaluated the significance of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in 30 patients with endometrial carcinoma and the relationship of those molecular markers to tumor characteristics and microvessel density (MVD). Immunohistochemical expression of COX-2, iNOS, and CD34 was analyzed on paraffin-embedded tissue sections. The COX-2 and iNOS positive rates were 66.7% and 73.3%, respectively. The level of COX-2 expression was higher in grade 11 tumors than in grade III tumors (p < 0.05). The percentage of iNOS positivity was higher in patients with deep myometrial invasion than in patients without or less than 50% myometrial invasion (p < 0.05). There was significant correlation between positive COX-2 and positive iNOS expression (r = 0.601, p < 0.001). Both COX-2 and iNOS were significantly correlated with MVD (r = 0.02 p < 0.05; r = 0.599 p < 0.0001, respectively). The present findings suggest that combined expression of COX-2 and iNOS may play an important role in development and invasion of endometrial cancer and that this could be partially attributable to modulation of angiogenesis by COX-2 and iNOS.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 43 条
[1]
Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression [J].
Ambs, S ;
Hussain, SP ;
Harris, CC .
FASEB JOURNAL, 1997, 11 (06) :443-448
[2]
Battu S, 1998, ANTICANCER RES, V18, P3579
[3]
Eroglu A, 1999, BRIT J CANCER, V80, P1630
[4]
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome [J].
Ferrandina, G ;
Legge, F ;
Ranelletti, FO ;
Zannoni, GF ;
Maggiano, N ;
Evangelisti, A ;
Mancuso, S ;
Scambia, G ;
Lauriola, L .
CANCER, 2002, 95 (04) :801-807
[5]
Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase [J].
Fujiwaki, R ;
Iida, K ;
Kanasaki, H ;
Ozaki, T ;
Hata, K ;
Miyazaki, K .
HUMAN PATHOLOGY, 2002, 33 (02) :213-219
[6]
Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer [J].
Fujiwaki, R ;
Hata, K ;
Iida, K ;
Koike, M ;
Miyazaki, K .
GYNECOLOGIC ONCOLOGY, 1998, 68 (03) :247-252
[7]
Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer [J].
Fujiwaki, R ;
Hata, K ;
Iida, K ;
Maede, Y ;
Watanabe, Y ;
Koike, M ;
Miyazaki, K .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (08) :728-734
[8]
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[9]
Jaiswal M, 2000, CANCER RES, V60, P184
[10]
Klimp AH, 2001, CANCER RES, V61, P7305